Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

<table>Kaplan-Meier analysis of the incidence of grade 3 peripheral neuropathy with respect to the dose of cumulative oxaliplatin in the GJG and non-GJG groups.</table>

Journal of Oncology

fig2

Figure 2

Figure 2: Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients 